ROUNDTABLES
Ubiquitin Conference Business Roundtables
The Ubiquitin Drug Discovery & Diagnostics conference is a best-in-class event where cutting-edge science meets business. In bringing together leaders in the clinical and pre-clinical fields of ubiquitin research, the event fosters relationships between small companies and big pharma. Simultaneously, it provides an opportune setting for academic scientists to explore products and technology ideas with industrial scientists.
The business roundtable component of the Ubiquitin Conference has become a tradition where leaders from both communities form lasting and mutually beneficial connections. Representatives from local, national and international companies, along with leading academic professionals, exchange ideas and share their unique perspectives on the business of ubiquitin research. From funding opportunities to scientific collaboration, the roundtable session fosters the sort of information and skillset exchange that is vital to the advancement of ubiquitin research in science and medicine
Real innovation in drug discovery cannot take place without a healthy and dynamic partnership between the academic and industrial spheres of scientific research. This relationship bridges the gap between basic research and practical application, from concept to reality... a relationship that benefits not just the scientific community, but ultimately - through the development of novel drugs and therapeutics - society as a whole.
The complexity of the ubiquitin system poses a number of large scientific problems - but through the interactive roundtable dialogue, industry and academia are able to achieve results far greater than what they might have attained independently.
(1) Pharma/Biotech Partnership: The Future of Drug Discovery
Pharma's traditional drug discovery model is changing as pharma continues to reduce R&D costs. It is also becoming more likely that the ubiquitome will provide a platform for the discovery of novel drugs. Will biotech play a role in filling the pipeline of pharma development? What are the elements of a successful pharma/biotech collaboration?
(2) From Lab to Market: Academia and Industry Collaboration
Both sessions will last approximately 45 minutes.
